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Abstract
Background: In all amyloid diseases, protein aggregates have been implicated fully or partly, in the etiology of the
disease. Due to their significance in human pathologies, there have been unprecedented efforts towards
physiochemical understanding of aggregation and amyloid formation over the last two decades. An important
relation from which hydrodynamic radii of the aggregate is routinely measured is the classic Stokes-Einstein
equation. Here, we report a modification in the classical Stokes-Einstein equation using a mixture theory approach,
in order to accommodate the changes in viscosity of the solvent due to the changes in solute size and shape, to
implement a more realistic model for Ab aggregation involved in Alzheimer’s disease. Specifically, we have focused
on validating this model in protofibrill lateral association reactions along the aggregation pathway, which has been
experimentally well characterized.
Results: The modified Stokes-Einstein equation incorporates an effective viscosity for the mixture consisting of the
macromolecules and solvent where the lateral association reaction occurs. This effective viscosity is modeled as a
function of the volume fractions of the different species of molecules. The novelty of our model is that in addition
to the volume fractions, it incorporates previously published reports on the dimensions of the protofibrils and their
aggregates to formulate a more appropriate shape rather than mere spheres. The net result is that the diffusion
coefficient which is inversely proportional to the viscosity of the system is now dependent on the concentration of
the different molecules as well as their proper shapes. Comparison with experiments for variations in diffusion
coefficients over time reveals very similar trends.
Conclusions: We argue that the standard Stokes-Einstein’s equation is insufficient to understand the temporal
variations in diffusion when trying to understand the aggregation behavior of Ab42 proteins. Our modifications
also involve inclusion of improved shape factors of molecules and more appropriate viscosities. The modification
we are reporting is not only useful in Ab aggregation but also will be important for accurate measurements in all
protein aggregation systems.
Introduction
Aberrant misfolding and aggregation of proteins have been
implicated in over 40 different human pathologies includ-
ing Alzheimer’s disease (AD), Parkinson’s disease, type 2
diabetes, transmissible spongiform encephalopathies (TSE)
or Prion diseases, Huntington’s disease and Cruedfelt-
Jacob disease (CJD). A biochemical commonality in these
diseases is that the protein involved forms pathogenic
aggregates, irrespective of whether the monomeric protein
is in the misfolded or intrinsically disordered forms, that
have a consensus structural moiety, commonly known as
“amyloids”. In all amyloid diseases, such protein aggregates
have been implicated fully or partly, in the etiology of the
disease. Due to their significance in human pathologies,
there have been unprecedented efforts towards physio-
chemical understanding of aggregation and amyloid for-
mation over the last two decades. It is well understood
that the process of aggregation towards amyloid fibrils
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from a monomeric state is a nucleation-dependant
mechanism, analogous to crystal growth. In such a pro-
cess, it is believed that there is a conformational change
during the nucleation event followed by rapid aggregation
to a state that forms large insoluble or soluble aggregates,
which in turn is accompanied by a structural convergence
to cross b-sheet conformation [1].
In Alzheimer’s disease (AD), a protein called amyloid-
b (Ab) peptide forms aggregates that deposit as senile
plaques in brains. The nucleation-dependent process of
Ab aggregation is inferred by the occurrence of a
‘lag-phase’ prior to fibril growth that shows a sigmoidal
pattern [2]. In the aggregation pathway, one important
intermediate called “protofibrils” has been isolated and
characterized by several groups [3][4][5][6][7][8]. Proto-
fibrils mainly differ from fibrils in their size and solubi-
lity; while fibrils can be sedimented with relatively
smaller forces (19000g, 10min)-where g is the accelera-
tion due to gravity- protofibrils require substantially
high sedimentation forces and have smaller diameters
than the fibrils [9]. Protofibrils have propensities to both
elongate (by monomer addition) as well as to laterally
associate (protofibril-protofibril association) to grow into
mature fibrils and have been well characterized [9].
These two mechanisms of fibril growth depend on the
structure and stability of protofibrils, which in turn
depend on the factors affecting nucleation.
The in vitro Ab aggregation process is well known to be
affected by several environmental factors such as concen-
tration, pH, ionic strength and temperature. In addition,
differential effects of solvents on the aggregation process
and size has also been documented [10]. Several biophysi-
cal methods are used to monitor the aggregation process
among which, light scattering and centrifugation techni-
ques are widely used to measure the hydrodynamic radii
(a) as well as the diffusion coefficient (D) of the protein
sample [5][11][12][13][14]. For spherical particles, the rela-
tion between a and D is given by the Stokes-Einstein (SE)
equation;
D
k T
a
B=
6 0ph
(1)
where, kB is Boltzmann’s constant, T is the absolute
temperature and h0 is solution viscosity. However, the
aggregates of Ab peptide cannot be assumed to be sphe-
rical and hence determination of a can be erroneous.
This difficulty is overcome by the use of multi-angle
light scattering (MALS) technique which measures the
intensity of the scattered light from multiple angles that
in turn helps to calculate the molecular weight without
assuming the shape of the solute [9]. A more sophisti-
cated method of measuring the molecular size is by ana-
lytical ultracentrifugation (AUC), which utilizes the rate
of the movement of sedimentation boundary [15]. For a
spherical solute with a molecular mass, MA and radius
a , the value of sedimentation coefficient measured at
temperature T in buffer b, the rate of migration per unit
field, sA is given by;
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where N is the Avogadro’s number and u A is the par-
tial specific volume of the solute, and r, h are the den-
sity and viscosity of the buffer medium respectively.
An important aspect of the Stokes-Einstein’s equation
and its utility in protein aggregation systems in particu-
lar is that the viscosity of the bulk solvent in a given
buffer solution is considered to be a constant.
Here, we are reporting a modification in the classical
Stokes-Einstein equation in order to accommodate the
changes in viscosity of the solvent due to the changes in
solvent size and shape, which is a more realistic model
for Ab aggregation. Specifically, we have focused on
validating this model in protofibril lateral association
reaction (Figure 1) along the aggregation pathway,
which has been experimentally well characterized [9,16].
The modification we are reporting is not only useful in
Ab aggregation but also will be important for accurate
measurement in all protein aggregation systems.
The classical SE model states that the diffusion coeffi-
cient for a suspension of molecules of a given volume
fraction in a surrounding solvent of viscosity h0 is written
as equation (1) where the denominator is the effective
drag coefficient for the molecule which is treated as a
rigid sphere of effective radius a. We point to several
shortcomings of this model with respect to the Ab aggre-
gation and suggest modifications to improve it which
include:
(i) firstly, molecules of concern to us are not necessa-
rily spheres [17] although this is the simplest assump-
tion one can make. In general for our problem, where
we consider the aggregation of molecules, several classes
of molecules (or n-mers) are assumed to populate the
solvent. While it is not clear what the specific shape of
each class (n-mer) is, it is most certainly not a sphere
[18] for the most part.
(ii) The second point we make is that the SE relation
takes the viscosity to be a constant, based upon the sol-
vent viscosity. However we argue that it should depend
upon the concentration of the various species of mole-
cules present in the system. Any single molecule (indivi-
dual or aggregated), during diffusion will experience the
viscous forces of the liquid as well as due to the remain-
ing molecules around it. As a result, the diffusion coeffi-
cient, k, is also a function of the concentration of the
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molecules. In fact, more generally, we will consider an
effective diffusion coefficient ke where ke = ke(ji,h0)
where i = 1, 2, …,n.
In this paper, we have considered these two important
conditions and incorporated modifications to the
Stokes-Einstein equation that may faithfully represent
the changes occurring in amyloid aggregation systems,
especially Ab. The significance of non-sphericity in
computing the diffusion coefficient has been realized in
various contexts and the biophysics, chemistry, geologi-
cal and chemical engineering literature is replete with
discussions of the role of non-spherical particles, specifi-
cally spheroidal particles [19-23]. While the biophysics
community has been well aware of the importance of
non-sphericity, the importance of concentration upon
the viscosity and hence diffusivity, has been largely
neglected. The chemical engineering literature is how-
ever a very rich source of discussion on this matter; see
[24] and references cited therein for more information
on this subject.
Results
Theoretical models
In a mixture or suspension containing a background
liquid and n-species of molecules, we define V0 to be
the volume of the solvent liquid and Vi, i = 1, 2,…, n to
be the volume of the i-th species. Then the volume frac-
tion of each element of this mixture is given by:
fk
k
k
k
n
V
V
=
=∑ 0
(3)
with the constraint:
f fi
i
n
=
∑ = + =
1
0 0 0 1Φ Φ, . (4)
Based upon these arguments, a general expression for
the diffusion coefficient for n-species of molecules can
be framed in terms of the volume fraction ji and must
be of the form:
k k
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f
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where j = 1, 2,…, n, fi refers to the drag coefficient of
the i-th species and bi, its respective shape coefficient.
As is seen from the last term on the right hand side of
the equation, the volume fraction enters the diffusion
coefficient through the viscosity. In fact, in this paper,
we suggest that the viscosity term itself be treated as an
average of the viscosity due to its constituents as a
Figure 1 Kinetics of Ab aggregation pathway. Schematic representation of the overall Ab aggregation towards fibril formation indicating
significant steps involved. The boxed area, which represents the conversion of protofibrils to fibrils via lateral association, is the reaction that is
being investigated in the current work.
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result of which hi(jj) is replaced by a scalar, the effec-
tive viscosity, he(jj) where j = 1, 2,…, n. Hence:
k
k T
e j
B
e j
i
ii
n
( , )
( )
.f h
h f
f
b0
1
=
=
∑ (7)
While we are following the vast majority of physics and
engineering literature in following this approach of mod-
eling a mixture through its overall material parameters,
we are also conscious that it not a rigorous mathematical
approach. In his paper on the “viscosities of mixtures”
Massoudi [24] provides an overview of the historical
approach to the modeling of effective viscosities but
more importantly, he points to the mathematically rigor-
ous approach of modeling a mixture by examining the
stress tensors. However, this is recognized to be a rather
formidable challenge to verify experimentally and very
tedious to implement in computations such as these.
Even within this approach of modeling viscosities, it has
been argued [25] that the effective viscosity of say two
liquids would be not just a linear superposition of the
two individual viscosities, but also include an interaction
term, referred to “mutual viscosity” which again is very
difficult to verify experimentally. All these point to the
complexity of rigorously modeling even a seemingly sim-
ple parameter as viscosity. In the rest of the paper, we
consider two specific and successful models applied in
the engineering literature to our problem of Ab aggrega-
tion. With regards to the shape of the molecules, there
has been much discussed about the validity of spherical-
shape assumption of biomolecules( [17,18] and references
therein) and while it is recognized that molecular shapes
can be fairly complex and random, it still remains worth-
while to represent these arbitrarily composed molecules
using some standard shapes that can be imagined
to envelope the molecules in a reasonable manner. Our
attempt in particular is to go beyond the assumption of
the sphere. To do so we need at our disposal, the drag
coefficients corresponding to arbitrarily shaped bodies.
This is a very daunting challenge in fluid mechanics and
at best relatively simpler shapes such as spheres, oblate
and prolate spheroids (of any eccentricity) have been ana-
lyzed mathematically [26,27]. However there is some lit-
erature in terms of empirical or computational relations
which provide the drag coefficients for other shapes.
Case 1: a sphere-rod empirical model
We begin with an empirical model. Based upon the
work of [28-31] we will consider the modification of the
SE law by taking a suspension composing of spheres
and rods with the former particles being considerably
smaller than the latter such that the ratio ar/as > 20,
where ar is the major axis of the rod and as is the
radius of the sphere. This particular assumption can
also be very meaningful in our case where we consider
our sample primarily to be composed of smaller mono-
mers and much larger protofibrils. In particular we
follow the specific approach of [31] in obtaining an
effective viscosity for such a suspension. In the words of
[31] the primary assumption in the computation of visc-
osity is that:
... for each fraction of a given particle size, the smaller
particles in suspension have the same effect as a homoge-
neous fluid with Newtonian viscosity similar to the effec-
tive viscosity of a suspension made up of the fraction of
smaller spheres. In other words, the smaller suspended
particles do not interact with the larger particles and are
’sensed’ by the large particles as part of the continuous
suspending fluid.
Mathematically, this amounts to saying that:
h h f h f hsus rel r r rel s s( ) ( ) ( ), ,Φ 0 0=
∗ (8)
where hrel,r(jr) refers to the viscosity of the rods rela-
tive to the continuum of a homogeneously distributed
spheres in a solvent, h frel s s, ( )
∗ , similarly is the viscosity
of the spheres relative to the continuum of the pure sol-
vent in the absence of the rods. Also, F0 = jr + js, jr
refers to the concentration of the rods, js the concen-
tration of spheres and:
f
f
fs
s
s
s
r
V
V V
∗ =
+
=
−0 1
. (9)
As in [31], based on the empirical relations suggested
by [32,33] we take:
h f f f frel s s s s e s,
.( ) . . .∗ ∗ ∗= + + +
∗
1 2 5 10 05 0 00272 16 6 (10)
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Using these above equations along with the shape fac-
tor 4
0 72
8
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pm pmba
L b r
a
L bln( / ) . ln( / ) .− +< < [27], where L, b refer to
the length and diameter respectively, depending on the
orientation of the rod, we have the relation for the diffu-
sion coefficient, namely:
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for the case of jr < 0.125. A similar relation can be
written for jr > 0.125 which is given by:
k
k T
e
r s
B
s s
s
( , , )
( . . . )(.
f f h
h f f f
0
0
2 16 61 2 5 10 05 0 0027 1 204
=
+ + + +∗ ∗
∗
0 63f
f
b
f
p
r
r
r
s
sa)
.+
⎛
⎝
⎜
⎞
⎠
⎟ (14)
If the net volume fraction of all the solute molecules is
held fixed (i.e. F), then the diffusion coefficient can be
written purely in terms of jr or js.
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Case 2: a mixture theory approach
In this section, we propose our model which is inspired
by the empirical approach mentioned above and the
viscosity model due to Quemada [34,35], who describes
the “viscosity of suspensions of hard spheres or of struc-
tural units like clusters or aggregates” using the relation:
h f
h
f f
( )
( / )
=
−
0
21 m
(15)
where h0 is the viscosity of the background solvent, j
is the volume fraction of the suspensions and jm is the
maximum volume fraction at which the viscosity
becomes singular, i.e. the critical limit of concentration
beyond which flow ceases. The literature estimates 0.58
<jm < 0.69 [36,37] (As in past literature, let us take the
average value, namely jm ≈ 0.6). In classical mixture
theory the effective viscosity of two liquids of different
viscosities has been taken to be the weighted average
viscosity of the components. In attempting to do the
same for suspensions, one must exercise a little caution.
In the model proposed here, we adopt a mixture
approach by trying to combine the solvent viscosity
appropriately with equation (15). We schematically dis-
play our recipe for obtaining a suspension with solvent
volume V0 and such that the volume of each constituent
particle (molecule) is Vi (i = 1, 2, …,n) in Figure 2, while
requiring that equations (3) and (4) be satisfied.
Hence, based upon the definitions earlier, we define
the effective viscosity as the weighted average of the
individual components given by:
h f f h h f f h
fe j j
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n
j
j
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i j
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where as in the sphere-rod model treated above, hi(i ≠ 0)
where i ranges over all cyclic permutations of (1, …, j, j + 1,
…,n), represents the relative viscosity of the suspension
containing the jth solute in a “solvent” composed of the
liquid of viscosity h0and all other solute particles. Note that
the equation (16) is not unique. Other formulations of the
effective viscosity are possible. The one provided here
seems mathematically and physically reasonable and con-
sistent with some models provided in the literature. The
term f i
j( ) represents the relative volume fraction of the j’th
solute relative to the “solvent” that contains it and is inde-
pendent for different j’s. Therefore, for an n-species sus-
pension, the viscosity relation for the j solute in a
background containing all other species and the pure sol-
vent can be inferred from the algorithm: hj ® hj+1® …
hn® h1® …hj–1 where ha ® hb indicates that ha is mea-
sured relative to hb in the sense of equation (8). In particu-
lar, the cyclic permutations of i are taken to ensure
evenness in the definition of the volume fractions, f i
j( ) for
all j’s. This is clearly illustrated in the cases of 2 and 3-spe-
cies which are examined in detail. We illustrate this by
means of a few examples.
(i) The case of two species
For instance, in the case of two solutes in a solvent, we
can write the effective viscosity as:
h f h f h f h= + +0 0 1 1 2 2 (17)
h
h h
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h
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1
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2
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−
=
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Figure 2 Mixture theory based approach to find the effective
viscosity. A schematic showing the the mixture theory approach of
estimating the effective viscosity of a 2-species suspension containing
the pure solvent (L), species 1(S1) and species 2(S2) by means of a
weighted average of the indivdual constituents of the suspension. The
tube 2 contains the pure solvent L of viscosity h0; tube 3 contains S1
floating in a medium composed L and S2 and is of viscosity h1; tube 4
contains S2 in a medium composed of L and S1 which is of viscosity
h2. By taking appropriate volumes from tubes 2,3 and 4, we prepare
the suspension in tube 1 which now contains L, S1 and S2 which has
an effective viscosity he defined in equation (16).
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(ii) The case of three species
We can write the effective viscosity as:
h f h f h f h f h= + + +0 0 1 1 2 2 3 3 (22)
h
h h h
f f f f1
3
0 6
2
2
0 6
2
0 6
2
0
1 1 1 11
1
3
1
1
1
2
1=
−
=
− −
=
−( ) ( ) ( ) (
( ) ( ) ( ) ( )
. . . 0 6
2
0 6
2
0 6
21 13
1
1
1
. . .) ( ) ( )
( ) ( )
− −f f
(23)
where
f f f2
1 2
2 0
3
1 3
3 2 0
1
1 1
1 3 2 0
( ) ( ) ( ), ,=
+
=
+ +
=
+ + +
V
V V
V
V V V
V
V V V V
(24)
and similarly,
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We can similarly extend the computation of the effec-
tive viscosity to any number of solute species. Hence
implementing this model into the above equation (7) for
ke gives:
k
k T
e n
B
e
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ii
n
( , , , )f f f h
h
y
b1 2 0
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⎠
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where he is defined by the equation (16) and
y i
V
V
i
jj
n=
=∑ 1 where i, j ≠ 0 that is, the fluid is dis-counted. Since the diffusion that we are interested in
only pertains to the solute species embedded in the sur-
rounding solvent, we need only consider the volume
fraction of each solute with respect to the others in the
evaluation of the effective diffusion. In particular let us
assume, for instance, that two classes (or species) or
molecules populate the solvent; the shape are so selected
since the shape factors are only known for a small class
of shapes. The first are the molecules at the protofibril
stage or beyond which are treated as being spheroidal in
shape(diffusion of spheroidal bodies had been consid-
ered as far back as 1936 by Perrin [38]) and the second
class are those smaller than the protofibril stage which
will be treated as spheres, even though Zwanzig and
Harrison [18] rightly argue that the shapes of molecules
are not correctly described by either of these shapes, the
latter being far more realistic than the former. We how-
ever feel that this is still an improvement over the cur-
rent approach of treating all the molecules as hard
spheres.
If we define the total volume fraction of the molecules
of both species to be F0 = 1, the volume fraction of the
spheroidal particles to be ψ, then the volume of spheri-
cal molecules can be given by 1 – ψ. For the two species
case we can write ψ1 = ψ and ψ2 = 1 – ψ. Therefore for
this example, we can write the effective viscosity as:
h h f
f f
f f f f
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by taking a weighted average of the appropriate viscos-
ities due to the three independent constituents. It must
be noted that while the spherical shape is devoid of any
orientational biases, the same cannot be said of the
spheroid which can move about in different orientations
( )0 2< <q
p . The drag on a spheroid can be a maxi-
mum or minimum depending upon the orientation of
the moving spheroid. We therefore estimate an upper
and lower limit of the diffusion coefficient for the spher-
oidal molecules k k ke
low
e e
high< < where the lower and
upper limits are obtained by the appropriate shape coef-
ficients. These values corresponding to the spheroid and
sphere (see Figure 3), respectively are known to be [26]
(the chemistry and biophysics literature, in this regards,
points to the model of Perrin [38]. We however use the
more correct formula derived by Chwang and Wu [26]
in 1975 using the Stokes singularity method):
b
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Where e b c= −1 2 2/ refers to the eccentricity of
the spheroid c and b refer to the major and minor axis
of the spheroid. Hence combining the above results
allows us to formulate a specific model for the two-spe-
cies case where the diffusion coefficient can be given by:
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It is not difficult to see that in the limit that the
spheroidal particles, vanish, i.e. the system contains the
spherical molecules and solvent alone ψ = 1 and the
effective diffusion coefficient can be written in the form:
ke
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which is still an improvement over the classical SE
model due to the accounting of the volume fraction in
the viscosity. The classical formula is retrieved by ignor-
ing the term ( )
( )
1 5 3
21− f and taking j0 + j = 1 based
on the constraint equation (4). For the one-species sus-
pension case when j/j0 = Î << 1, then equation (33)
can be approximately written at O(Î) as:
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where j(1) = j. As Î ® 0, the diffusion coefficient
approaches the classical Stokes Einstein equation since
then j0® 1.
Protofibril-protofibril lateral association experiment
Protofibril lateral association reaction was initiated by
the addition of 150 mM NaCl to the isolated protofi-
brils (3 and 5 µM) that was monitored by dynamic light
scattering (DLS) instrument. Protofibrils without salt
were used as a negative control. The data is plotted in
Figure 4 against diffusion coefficient (D) which is inver-
sely proportional to the hydrodynamic radius of the
sample.
Molecular level simulation of protofibril-protofibril lateral
association
Next, we used some simple molecular level reaction mod-
els to predict the concentration of protofibrils of different
size in the lateral association stage that can correspond to
the diffusion coefficient estimates from DLS reported
above. First, we assumed that the protofibrils are composed
of 1600 monomers based on the previous reports [39,40].
Here, F1600 denote the protofibrils (comprising 1600-mers
and average length 64 nm) [39,40]. In general, we will let Fi
denote a protofibril with i number of Ab molecules binding
to it during the lateral association phase.
We present separate reaction models considering dif-
ferent number of species formed during the lateral asso-
ciation reaction. The reactions involving these species
were modeled under the assumption of a homogeneous
mixture of protofibrils (with different initial concentra-
tions) as used in the in vitro experiments. In particular,
Figure 3 Shapes of macromolecules and lateral association
orientation. The figures (i) and (ii) show the two different plausible
shapes used to represent the protofibrils along with their
appropriate dimensions. In the past these molecules have been
represented as spheres for the most part. Based on experimental
observations we suggest that a prolate spheroidal shape is more
appropriate. Figure (iii) indicates the association mechanism of two
spheroidal molecules. Since the ratio b
c << 1 , we can effectively
assume that the association of two spheroids creates another
spheroid with major and minor axes c and 2b, respectively.
Figure 4 Experimental esimation of diffusion coefficient versus
time. The lateral protofibrils association process monitored by
dynamic light scattering (DLS). Isolated protofibrils (3 or 5 µM) of
Ab42 buffered in 20 mM Tris-HCl, pH 8.0 was allowed to associate
by the addition of 150 mM NaCl at room temperature. The reaction
was monitored using DLS instrument for the shown period of time.
The control sample was 5 µM protofibril sample in the absence of
NaCl.
Achuthan et al. BMC Bioinformatics 2011, 12(Suppl 10):S13
http://www.biomedcentral.com/1471-2105/12/S10/S13
Page 7 of 13
we considered a maximum of five different molecular
species involved in this phase as follows: F1600, F3200,
F4800 , F6400 and F8000. We have assumed that lateral
association will result in at most a 5-fold increase in
size of the protofibrils within the first 1.5 hrs of obser-
vation such that the system of reactions will not involve
the formation of protofibrils beyond F8000. This assump-
tion is purely theoretical although it is experimentally
well known that three protofibrils associate together to
form mature fibrils. We wanted to consider upto 5 spe-
cies for the interest of modeling and calculations. The
reaction fluxes in this are denoted by R(i, j) correspond-
ing to the reaction between Fi*1600 and Fj*1600 forming F
(i+j)*1600 for i = 1, …, 5 and j = i, i + 1,…, 5 – i. We
have also assumed that the initial concentration of pro-
tofibrils comprise of only F1600’s and that of the other
species are zero in the reaction models as only minute
levels of associated protofibrils are expected to be pre-
sent initially in the in vitro system.
In the following, we have considered three case studies
to estimate the concentration change of the different
molecular species involved in lateral association: 2-spe-
cies (F1600, F3200), 3-species (F1600, F3200, F4800) and 5
species (F1600, F3200, F4800, F6400, F8000). Each reaction
was considered reversible with k+ and k– being the for-
ward and backward rate constants respectively. Follow-
ing our previously validated lateral association stage
model [16], we have considered k+ = 9.0 × 10
–1h–1mM–
1 and k– = 6.0 × 10
–3h–1 respectively. While the 2-spe-
cies and 3-species models are less realistic, we have seen
that protofibrils do not grow beyond F8000 in the first
1.5 hrs of lateral association, and hence the 5-species
model should be the best approximation of the in vitro
system under study.
Case 1: 2-species reaction model
F F F
R k F F k F
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+
= −
+
−
+ −
  
( , ) [ ][ ] [ 3200
1600 32002 1 1 1 1
]
( , ); ( , )
dF
dt
R
dF
dt
R= − =
Case 2: 3-species reaction model
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Case 3: 5-speciesreaction model
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After the kinetic schemes are established in the reac-
tion models above, we computed the corresponding reac-
tion fluxes, and hence the differential equations that
govern the temporal change of these species can be
derived from material balances and reaction kinetics. The
reaction flux and differential equations for each of the
models reported here have also been shown alongside.
The initial concentration of protofibrils ([F1600]) is set to
1µM, 3µM and 5µM respectively following the in vitro
experiments while the concentrations of the other species
are assumed to be zero at the start (i.e., [Fi*1600] = 0, i = 2,
…, 5). Thus, the system of differential equations for each
model is properly defined and were solved using Matlab’s
ODE toolbox to estimate the concentration of the differ-
ent species at various time points between 0 – 90 mins as
shown in the previous section.
Case studies
In this section, we consider some special cases to test
our proposed models. We consider the cases of two,
three and five species embedded in a solvent, introduced
earlier. In these examples, we consider each species to
be an ellipsoid since the length and width of the mole-
cules considered here are significantly different so they
cannot be correctly represented as spheres. As is indi-
cated in Figure 3(c), associations of these spheroids
occur laterally; therefore according to our model, the
result of n-associations of spheroids of major axis c and
minor axis b results in a new spheroid with major axis c
and minor axis n × b. Our objective is to employ our
model to estimate the effective diffusion coefficient of
various systems and compare them to the experimen-
tally measured values of diffusion.
For our calculations, we take the dimensions of the
protofibril (1600-mer) to be a spheroid with minor axis
equal to 2.25nm and the major axis to be 300nm based
upon previously published reports [8,9,41]. Also we take
the viscosity of the solvent (water) to be 0.89 × 10–3 Pa-s.
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The results of our computations are plotted in Figure 5.
The right columns of this plot (Figures 5D, E and F)
show the results of the experiments which yield the diffu-
sion coefficient and the concentrations alike. The initial
concentration of the protofibril is taken to be 5µM in
each of the cases. The black points in the curves refer to
the 1600 mers while the red points refer to the final stage
in each case, i.e. 3200mers in the 2-species case, 4800
mers in the 3 species and the 8000 mers in the 5 species
case. Note that the diffusion coefficient always decreases
with the diminishing 1600 mers on the other hand grow-
ing with the diminishing concentrations of the bigger,
associated molecule. The panels on the left hand side
(Figures 5A, B and C) indicate the results of the numeri-
cal computations for the same cases as the experiments
and indicate very similar trends. For ease of comprehen-
sion of the plots the values of ke
high alone are shown in
the graphs here while those of ke
low show very similar
Figure 5 Experimental and theoretical comparison of the diffusion coefficient. This figure shows the variation in diffusion coefficient of
1600-, 3200-, 4800- and 8000-mers corresponding to their concentrations for the three case studies of 2-(row 1), 3-(row 2) and 5-species(row 3).
The panels on right show the experimental results while those on the left correspond to the theroretical predictions. Each panel shows two
curves; the black curves represent the diffusion coefficients of the smallest molecules (1600-mers in each case) while the red curves represent
the diffusion coefficients of the largest molecules namely: 3200-mers, 4800-mers and 8000-mers respectively corresponding to the 2-,3- and 5-
species cases.
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features. It is to be noted that the black and red points do
not actually intersect; the intersection is an artefact of the
two different scales represented on the y-axis. While the
increasing and decreasing trends remain consistent with
observations the actual value of the diffusion coefficient
seems to differ. Our model puts the lower and upper
limit values of the diffusion coefficient consistently
between 1.7 × 10–12m2/s and about 2.4 × 10–12m2/s while
experimental values are higher, ranging upto four times
more that our upper limit at some concentrations. Firstly
the large variability in the experimental data when com-
pared to our model can be attributed to the fact that the
experimental study is based upon DLS observations
which provides a time varying effective radius for the sys-
tem, corresponding to the production of larger molecules
which form as a result of the association. These experi-
mentally evaluated radii which range between 30-80nm
are then inserted into the classical Stokes-Einstein
formula (equation (1)) to get the diffusion coefficient.
The experimental estimates for the effective length scale
are substantially lower than the more accurate values
used in our model, resulting in the deviation from our
values of the diffusion coefficient.
Certain features of the computations merit immediate
attention. In particular, the profile of the 1600, 3200 and
8000mers is striking. These include the declining values of
the apparent intersection point with increasing number of
species and also the slope of the red curves whose declin-
ing trend in the graph as plotted, gets more rapid with the
larger molecule.
The most significant contribution of the paper lies in the
suggestion that the viscosity of the system is not a con-
stant as considered so far but depends strongly upon the
concentration of the various molecules. In Figure 6, we
plot the change in the effective viscosity of the 2-, 3- and
5-species cases as a function of the concentrations of the
Figure 6 Variation of effective viscosity with concentration. Figures A,B,C and D show variations in the effective viscosity versus
concentration in the 5-species example for 1600-mers, 3200-mers, 4800-mers and 8000-mers respectively. The figure A shows that the effective
viscosity is directly proportional to the concentration of the 1600-mers while B,C and D reveal it to be inversely proportional to the respective
concentrations.
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1600, 3200, 4800 and 8000 mers. A clear declining trend is
observed which is in agreement with the literature [42-44].
Viscosity of suspensions have been known to diminish
with the declining concentrations of the solute. On the
other hand viscosity increases with the decreasing size of
the solute particles since smaller particles are capable of
more random Brownian motions causing greater retarda-
tion of the bulk fluid motion. The approach proposed in
this paper must not be thought simply as a reaction to the
DLS estimates which essentially uses the equation (1). As
one can note from equation (2), even the AUC method
relies upon the drag formula corresponding to a sphere
and the viscosity of the buffer does not depend upon the
volume fraction of the embedded solutes.
Discussion and future work
The intention of this paper is to point out a somewhat
erroneous practice of employing the Stokes-Einstein
(SE) formula in situations which are not represented by
it accurately enough. The proposed modification is a
first in a series of steps that will help provide better
mathematical models that fully incorporate all features
of the entire system to explain protein aggregation.
While the shape factor and concentration are intro-
duced as tuning parameters, the central contribution of
this paper lies in the realization that the meaning of
“viscosity”(denoted h0) in the Stokes-Einstein formula is
the one pertaining to the solvent alone. However if one
wants to think of the diffusion of any molecule, the
effective medium becomes the solvent as well as the
remaining molecules embedded in the system. Therefore
the solvent viscosity of the classical SE formula needs to
be replaced appropriately with one of an effective viscos-
ity which is no longer just the solvent viscosity alone. In
fact the concentration terms are as important if not
more than the non-sphericity requirement. It is also
important to note that while the apparent form of the
modified SE formula is similar to that of the classical SE
formula, our model has grave implications in under-
standing the dynamics of the protofibrils and aggregate
molecules since the diffusion coefficient is no longer a
constant but a function of the shape factors and concen-
trations of the different species of molecules that popu-
late the suspension. While the change from a sphere to
a spheroid might appear to be a minor point, its full
impact can only be realized when one studies the pro-
blem at the smaller scale where this change can display
its full impact as we plan to do in the future; this paper
is focused on the larger scale continuum properties of
the system as experimental measurements were hard to
achieve at a smaller scale for the protein aggregation
problem. To see the complexity of this model, one need
only look at the diffusion equation that our model
generates. For instance, in the case of n-species of
n-mers embedded in a solvent,
∂
∂ = ∇
f f f b b fit e ikdiv ( ( , , , , , ) )1 2 1 2  (35)
where i = 1,2,…,n. The new ke renders the equation
highly nonlinear. The modified SE equation provided in
this paper now allows for a more appropriate coupling of
the solute-solvent dynamics. Under the realistic condi-
tions of flow we have a two way coupling; the dynamics
of the solute is described by the concentration equation
(35), while the dynamics of the solvent would be given by
the Navier-Stokes equation. Our next goal is to take on
this multiscale approach coupled with a reaction term to
understand the temporal and spatial variations in the
solute (protofibrils and aggregates) distribution. Due to
the contributions of this paper, this would be a very new
and rigorous addition to the biophysics literature. The
model proposed here, therefore merits serious attention
since it provides a systemic treatment of the biophysics
involved. The current paper is therefore a first step in
this long term approach of understanding the problem of
protein aggregation thoroughly and rigorously.
Conclusion
In this report, we have shown that the use of classical
Stokes-Einstein equation may not be accurate for the mea-
surement of hydrodynamic radii and consequently mole-
cular weights of amyloid aggregates. Although it is known
that appropriate assumption of the shape of solute mole-
cules is essential for accurate size determination while
using Stokes-Einstein equation, this is the first time we
have shown that it is incorrect to assume solvent viscosity
be a constant during the reaction. This is particularly true
for reactions involving Ab protofibrils, as large size of the
solute molecules indicate significant effect on bulk solvent
viscosity. We have attempted to rectify the problem by
incorporating modifications to the Stokes-Einstein equa-
tion (Equation 16)that seem to be valid for the protofibril
lateral association reaction. It is noteworthy that the modi-
fications reflecting the viscosity changes can lead to realis-
tic models not only for Ab aggregation but also for a
majority of amyloid aggregation systems.
Methods
Ab protofibril preparation
Synthetic Ab42 peptide was obtained from synthesis
facility at Mayo Clinic, Rochester, MN as a lyophilized
powder. Ab42 protofibrils were generated and isolated
as previously reported (9). Freshly purified Ab42 mono-
mers (100 µM) from size exclusion chromatography buf-
fered in 10 mM Tris, 50 mM NaCl, pH 8.0 was agitated
at room temperature for 48 h. The aggregation was
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monitored using ThT fluorescence. The sample was
then centrifuged at 19000g for 12 min to spin out any
fibril that may have formed. The supernatant was then
fractionated by Superdex-75 size exclusion column to
isolate protofibrils from unreacted monomers and smal-
ler oligomers. The concentration of protofibrils was
measured by UV-Vis with a molar extinction coefficient
of 1450 cm–1M–1 corresponding to Ab42.
Dynamic light scattering (DLS)
The DLS experiments were performed using Zetasizer
nanoseries instrument ( Malvern Instruments, Inc.). The
samples were equilibrated for 120s and a total of 90
measurements of 10s each were made with a time inter-
val of 1min after each measurement. The data was
exported as diffusion coefficient using Zetasizer software
version 6.20 and processed using origin 6.0 software.
Reaction flux and differential equations for the reaction
pathway
After the kinetic schemes for each of the three reaction
models are established, the concentrations of the various
species can be expressed as functions of time by using
material balances and reaction kinetics. We will explain
the 5-species reaction model in this section, while the
other two models can be derived similarly. The reaction
fluxes for the 5-species model can be derived as follows:
R i j k F F k F i j i ii j i j( , ) [ ][ ] [ ]; , , ; ,( )= − ∀ = =+ × × − + ×1600 1600 1600 1 5 + −1 5, , i
Next, we formulate the differential equations for each
species in the system to model their change in concen-
tration with time. The first species to be considered is
F1600 whose rate of change is expressed in terms of its
disappearance:
dF
dt
R R R R1600 2 1 1 1 2 1 3 1 4= − − − −( , ) ( , ) ( , ) ( , );
(and hence the negative sign before each reaction flux
term) due to each of the reactions involving F1600
enlisted in 5-species reaction model. Similarly, the dif-
ferential equations of each of the other species involved
can be written based on the fluxes of the reactions
where the species is produced (positive terms) or con-
sumed (negative terms):
dF
dt
R R R R
dF
dt
R R
3200
4800
1 1 1 2 2 2 2 2 3
1 2 1
= − − −
= −
( , ) ( , ) ( , ) ( , );
( , ) ( ,3 2 3
1 3 1 4 2 2
1 4
6400
8000
) ( , );
( , ) ( , ) ( , );
( , )
−
= − +
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R
dF
dt
R R R
dF
dt
R R( , );2 3
The initial concentration of F1600s is equal to the
amount of protofibrils added initially and is the main
driving force for the downstream reactions. The concen-
trations of the other species are assumed to be zero at
the start (i.e., [Fi×1600] = 0, i = 1, …, 5). This set of dif-
ferential equations is properly defined and can be solved
using Matlab’s ode15s.
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